These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 32121394)

  • 1. The Fate of Th17 Cells is Shaped by Epigenetic Modifications and Remodeled by the Tumor Microenvironment.
    Renaude E; Kroemer M; Loyon R; Binda D; Borg C; Guittaut M; Hervouet E; Peixoto P
    Int J Mol Sci; 2020 Feb; 21(5):. PubMed ID: 32121394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Th17 Cell Plasticity and Functions in Cancer Immunity.
    Guéry L; Hugues S
    Biomed Res Int; 2015; 2015():314620. PubMed ID: 26583099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The connection between the Th17 cell related cytokines and cancer stem cells in cancer: Novel therapeutic targets.
    Shahid A; Bharadwaj M
    Immunol Lett; 2019 Sep; 213():9-20. PubMed ID: 31278971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between Th17 cells and tumor microenvironment.
    Qi W; Huang X; Wang J
    Cell Immunol; 2013; 285(1-2):18-22. PubMed ID: 24044962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-6/STAT3 pathway induced deficiency of RFX1 contributes to Th17-dependent autoimmune diseases via epigenetic regulation.
    Zhao M; Tan Y; Peng Q; Huang C; Guo Y; Liang G; Zhu B; Huang Y; Liu A; Wang Z; Li M; Gao X; Wu R; Wu H; Long H; Lu Q
    Nat Commun; 2018 Feb; 9(1):583. PubMed ID: 29422534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine-regulated Th17 plasticity in human health and diseases.
    Cerboni S; Gehrmann U; Preite S; Mitra S
    Immunology; 2021 May; 163(1):3-18. PubMed ID: 33064842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Epigenetic Regulation in Plasticity of Tumor Immune Microenvironment.
    Yang Y; Wang Y
    Front Immunol; 2021; 12():640369. PubMed ID: 33868269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of T helper 17 and regulatory T cells in tumor microenvironment.
    Najafi S; Mirshafiey A
    Immunopharmacol Immunotoxicol; 2019 Feb; 41(1):16-24. PubMed ID: 30714422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic changes at Il12rb2 and Tbx21 in relation to plasticity behavior of Th17 cells.
    Bending D; Newland S; Krejcí A; Phillips JM; Bray S; Cooke A
    J Immunol; 2011 Mar; 186(6):3373-82. PubMed ID: 21307296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased IL-17-producing CD4(+) T cells in patients with esophageal cancer.
    Chen D; Hu Q; Mao C; Jiao Z; Wang S; Yu L; Xu Y; Dai D; Yin L; Xu H
    Cell Immunol; 2012; 272(2):166-74. PubMed ID: 22082565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cellular and molecular view of T helper 17 cell plasticity in autoimmunity.
    Stadhouders R; Lubberts E; Hendriks RW
    J Autoimmun; 2018 Feb; 87():1-15. PubMed ID: 29275836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The histone H3 lysine-27 demethylase Jmjd3 plays a critical role in specific regulation of Th17 cell differentiation.
    Liu Z; Cao W; Xu L; Chen X; Zhan Y; Yang Q; Liu S; Chen P; Jiang Y; Sun X; Tao Y; Hu Y; Li C; Wang Q; Wang Y; Chen CD; Shi Y; Zhang X
    J Mol Cell Biol; 2015 Dec; 7(6):505-16. PubMed ID: 25840993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolites in the Tumor Microenvironment Reprogram Functions of Immune Effector Cells Through Epigenetic Modifications.
    Li Y; Wu Y; Hu Y
    Front Immunol; 2021; 12():641883. PubMed ID: 33927716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myeloid derived suppressor cells (MDSCs) can induce the generation of Th17 response from naïve CD4+ T cells.
    Chatterjee S; Das S; Chakraborty P; Manna A; Chatterjee M; Choudhuri SK
    Immunobiology; 2013 May; 218(5):718-24. PubMed ID: 22995935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding the epigenetic regulation of tumours and their microenvironments: opportunities and problems for epigenetic therapy.
    Liu M; Zhou J; Chen Z; Cheng AS
    J Pathol; 2017 Jan; 241(1):10-24. PubMed ID: 27770445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-17+Foxp3+ T cells: an intermediate differentiation stage between Th17 cells and regulatory T cells.
    Du R; Zhao H; Yan F; Li H
    J Leukoc Biol; 2014 Jul; 96(1):39-48. PubMed ID: 24744433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacologic inhibition of RORγt regulates Th17 signature gene expression and suppresses cutaneous inflammation in vivo.
    Skepner J; Ramesh R; Trocha M; Schmidt D; Baloglu E; Lobera M; Carlson T; Hill J; Orband-Miller LA; Barnes A; Boudjelal M; Sundrud M; Ghosh S; Yang J
    J Immunol; 2014 Mar; 192(6):2564-75. PubMed ID: 24516202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased expression of IRF8 in tumor cells inhibits the generation of Th17 cells and predicts unfavorable survival of diffuse large B cell lymphoma patients.
    Zhong W; Xu X; Zhu Z; Du Q; Du H; Yang L; Ling Y; Xiong H; Li Q
    Oncotarget; 2017 Jul; 8(30):49757-49772. PubMed ID: 28537908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signaling Pathways and Epigenetic Regulations in the Control of RORγt Expression in T Helper 17 Cells.
    Tian Y; Wu Y; Ni B
    Int Rev Immunol; 2015; 34(4):305-17. PubMed ID: 24801756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PPARα suppresses Th17 cell differentiation through IL-6/STAT3/RORγt pathway in experimental autoimmune myocarditis.
    Chang H; Zhao F; Xie X; Liao Y; Song Y; Liu C; Wu Y; Wang Y; Liu D; Wang Y; Zou J; Qi Z
    Exp Cell Res; 2019 Feb; 375(1):22-30. PubMed ID: 30557558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.